首页>
外国专利>
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF LIVER CELLS OR LIVER DISEASE, CONTAINING FUCOSTEROL SEPARATED FROM PELVETIA SILIQUOSA EXTRACT
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF LIVER CELLS OR LIVER DISEASE, CONTAINING FUCOSTEROL SEPARATED FROM PELVETIA SILIQUOSA EXTRACT
展开▼
机译：预防和治疗百日咳提取物分离出的富固甾醇的肝细胞或肝病的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A pharmaceutical composition containing fucosterol separated from Pelvetia siliquosa extract exhibiting liver-protecting activity is provided. The fucosterol increases antioxidant enzyme activity such as SOD, catalase and GSH-px while reducing sGOT and sGPT and thus can be used as a pharmaceutical composition for prevention and treatment of liver cells or liver disease. CONSTITUTION: The pharmaceutical composition contains 0.01 to 50% by weight of fucosterol separated from Pelvetia siliquosa extract, based on the total weight of the pharmaceutical composition as an effective ingredient. It exhibits liver-protecting activity such as prevention and treatment of virus-induced alcoholic fatty liver, chronic hepatitis, liver cirrhosis and hepatoma. For an example, 100mg fucosterol is mixed with 50mg lactose, 50mg starch, 2mg talc and a suitable amount of magnesium stearate to give a capsule.
展开▼
